In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Batra And Galinat Appointed To Merck Board

This article was originally published in Scrip

Executive Summary

E. Merck KG, the family holding company of Merck KGaA, has appointed Udit Batra, head of the life science business sector, and Walter Galinat, head of the performance materials business sector, to Merck KgaA's executive board – effective April, 30. 2016. Current board member Bernd Reckmann, will retire from his position – effective April. 30, 2016. Galinat joined Merck as an apprentice in 1976 and after earning his degree he built up the local Merck subsidiary in Taiwan. Later on in his career, he was head of the laboratory products division, head of the former Liquid Crystals division and was appointed CEO and president of today's performance materials business sector. Before joining Merck, Batra was at Novartis, where he was head of global public health and market access for vaccine and diagnostics, global head of corporate strategy and country president of the pharmaceutical business in Australia. He joined Merck in 2011, taking over leadership of the consumer health business and was later appointed CEO and president of Merck Millipore.






Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts